Manganese-induced reactive oxygen species activate IκB kinase to upregulate YY1 and impair glutamate transporter EAAT2 function in human astrocytes in vitro.
Astrocytes
/ drug effects
Cells, Cultured
Excitatory Amino Acid Transporter 2
/ antagonists & inhibitors
Humans
I-kappa B Kinase
/ metabolism
Manganese
/ toxicity
Oxidative Stress
/ drug effects
Reactive Oxygen Species
/ metabolism
Up-Regulation
/ drug effects
YY1 Transcription Factor
/ biosynthesis
EAAT2
Manganese
NF-κB
Oxidative stress
TNF-α
YY1
Journal
Neurotoxicology
ISSN: 1872-9711
Titre abrégé: Neurotoxicology
Pays: Netherlands
ID NLM: 7905589
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
07
06
2021
revised:
14
07
2021
accepted:
21
07
2021
pubmed:
27
7
2021
medline:
5
2
2022
entrez:
26
7
2021
Statut:
ppublish
Résumé
Dysregulation of the astrocytic glutamate transporter excitatory amino acid transporter 2 (EAAT2) is associated with several neurological disorders, including Parkinson's disease, Alzheimer's disease, and manganism, the latter induced by chronic exposure to high levels of manganese (Mn). Mechanisms of Mn-induced neurotoxicity include impairment of EAAT2 function secondary to the activation of the transcription factor Yin Yang 1 (YY1) by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). However, the upstream mechanisms by which Mn-induced NF-κB activates YY1 remain to be elucidated. In the present study, we used the H4 human astrocyte cell line to test if Mn activates YY1 through the canonical NF-κB signaling pathway, leading to EAAT2 repression. The results demonstrate that Mn exposure induced phosphorylation of the upstream kinase IκB kinase (IKK-β), leading to NF-κB p65 translocation, increased YY1 promoter activity, mRNA/protein levels, and consequently repressed EAAT2. Results also demonstrated that Mn-induced oxidative stress and subsequent TNF-α production were upstream of IKK-β activation, as antioxidants attenuated Mn-induced TNF-α production and IKK-β activation. Moreover, TNF-α inhibition attenuated the Mn-induced activation of IKK-β and YY1. Taken together, Mn-induced oxidative stress and TNF-α mediates activation of NF-κB signaling and YY1 upregulation, leading to repression of EAAT2. Thus, targeting reactive oxygen species (ROS), TNF-α and IKK-β may attenuate Mn-induced YY1 activation and consequent EAAT2 repression.
Identifiants
pubmed: 34310962
pii: S0161-813X(21)00082-6
doi: 10.1016/j.neuro.2021.07.004
pmc: PMC8440474
mid: NIHMS1730851
pii:
doi:
Substances chimiques
Excitatory Amino Acid Transporter 2
0
Reactive Oxygen Species
0
SLC1A2 protein, human
0
YY1 Transcription Factor
0
YY1 protein, human
0
Manganese
42Z2K6ZL8P
I-kappa B Kinase
EC 2.7.11.10
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
94-103Subventions
Organisme : NIMHD NIH HHS
ID : U54 MD007582
Pays : United States
Organisme : NCI NIH HHS
ID : SC1 CA200519
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES020852
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES024756
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES031282
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES010563
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
Int J Mol Sci. 2019 Nov 13;20(22):
pubmed: 31766111
Cell Res. 2011 Jan;21(1):103-15
pubmed: 21187859
J Neurosci. 2006 May 10;26(19):5256-64
pubmed: 16687518
EMBO J. 2005 Feb 9;24(3):510-20
pubmed: 15660126
Nat Chem Biol. 2006 May;2(5):249-53
pubmed: 16565714
Food Chem Toxicol. 2019 Mar;125:583-594
pubmed: 30738988
Arch Dermatol Res. 2016 Dec;308(10):733-742
pubmed: 27744496
Exp Ther Med. 2019 Oct;18(4):2859-2866
pubmed: 31572531
Cell Mol Life Sci. 2015 Sep;72(18):3489-506
pubmed: 26033496
J Neurochem. 2010 Mar;112(5):1190-8
pubmed: 20002294
Brain Res Brain Res Rev. 2004 Jul;45(3):250-65
pubmed: 15210307
J Cell Physiol. 2011 Oct;226(10):2484-93
pubmed: 21792905
Nat Immunol. 2008 Dec;9(12):1371-8
pubmed: 18997794
Neurochem Int. 2015 Sep;88:53-9
pubmed: 25128239
FEBS J. 2021 Jan;288(2):640-662
pubmed: 32386462
J Trace Elem Med Biol. 2011 Dec;25(4):191-203
pubmed: 21963226
Mol Cell Biol. 2007 Jun;27(12):4374-87
pubmed: 17438126
Redox Biol. 2021 May;41:101917
pubmed: 33711713
Neurochem Res. 2015 Feb;40(2):402-9
pubmed: 25380696
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000158
pubmed: 20300203
Neurosci Lett. 2015 Mar 4;589:73-8
pubmed: 25596441
Neurochem Res. 2014 Jan;39(1):150-60
pubmed: 24277080
Metallomics. 2017 Sep 20;9(9):1251-1259
pubmed: 28661534
Sci Rep. 2014 Oct 28;4:6801
pubmed: 25348053
Biochem Biophys Res Commun. 2013 Sep 6;438(4):628-34
pubmed: 23933318
Toxicol Lett. 2002 Dec 15;136(2):151-8
pubmed: 12425965
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33925013
Mol Neurobiol. 2014 Feb;49(1):380-5
pubmed: 23990375
Clin Pharmacol Ther. 2019 Oct;106(4):884-890
pubmed: 31206613
Int J Mol Sci. 2020 Dec 17;21(24):
pubmed: 33348528
J Neurochem. 2009 Aug;110(3):822-30
pubmed: 19457077
Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1850-8
pubmed: 19363130
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):219-25
pubmed: 19607852
Oncol Rep. 2017 Jun;37(6):3397-3404
pubmed: 28440462
J Pers Nanomed. 2015;1(1):3-9
pubmed: 26635971
J Biol Chem. 2015 Sep 25;290(39):23725-37
pubmed: 26269591
J Biol Chem. 2013 Oct 4;288(40):28975-86
pubmed: 23955341
Toxicol In Vitro. 2008 Feb;22(1):18-27
pubmed: 17845838
Neuropharmacology. 2019 Dec 15;161:107559
pubmed: 30851309
Neurotoxicology. 2018 Mar;65:280-288
pubmed: 29183790
Cell Signal. 2019 Mar;55:17-25
pubmed: 30543861
Oncogene. 2014 Mar 6;33(10):1297-305
pubmed: 23474754
Drug Des Devel Ther. 2019 Apr 11;13:1155-1162
pubmed: 31043768
Oxid Med Cell Longev. 2015;2015:610813
pubmed: 25834699
J Alzheimers Dis. 2016 Jul 13;53(2):745
pubmed: 27434286
Mol Psychiatry. 2007 Dec;12(12):1065-78
pubmed: 17684493
Future Med Chem. 2012 Sep;4(13):1689-700
pubmed: 22924507
Acta Neurol Belg. 2015 Sep;115(3):221-32
pubmed: 25539775
Can J Physiol Pharmacol. 2018 Dec;96(12):1189-1196
pubmed: 30107137
Mol Cell Biol. 2014 Apr;34(7):1280-9
pubmed: 24469401
Expert Rev Neurother. 2020 Nov;20(11):1109-1121
pubmed: 32799578
Neurobiol Dis. 2015 Dec;84:78-83
pubmed: 25913028
Curr Cancer Drug Targets. 2015;15(2):145-57
pubmed: 25817371
PPAR Res. 2020 Mar 6;2020:2410264
pubmed: 32206061